Lonza | LONN - Capital De Empréstimo





Capital De Empréstimo Alterar Data
Akzo Nobel EUR 4.76B 1.09B 2026-03
Alcon AG USD 4.16B 434M 2026-03
Almirall EUR 324.81M 61.32M 2025-12
AstraZeneca USD 25.96B 177M 2026-03
BASF EUR 18.48B 447M 2025-12
Bayer EUR 30.68B 1.15B 2026-03
Beiersdorf EUR 117M 15M 2025-12
Covestro EUR 1.67B 408M 2025-12
Demant DKK 18.98B 3.71B 2025-12
Fresenius EUR 9.22B 1.58B 2025-12
Fresenius Medical Care EUR 5.74B 895.27M 2026-03
Geberit CHF 1.35B 25.4M 2025-09
Genmab DKK 5.14B 5.01B 2025-12
Givaudan CHF 4.19B 448M 2025-12
GlaxoSmithKline GBP 14.01B 696M 2026-03
GN Store Nord DKK 8.1B 790M 2026-03
Hikma Pharmaceutical USD 1.49B 692M 2025-12
Johnson Matthey GBP 1.34B 3M 2025-12
Merck EUR 10.8B 72M 2026-03
Novartis USD 37.45B 7.86B 2026-03
Philips EUR 6.89B 43M 2026-03
Roche Holding CHF 27.43B 966M 2025-12
Sanofi EUR 13.84B 1.88B 2026-03
Sika AG CHF 4.13B 1.4B 2025-12
Smith & Nephew USD 3.3B 22M 2025-12
Solvay EUR 1.83B 8M 2026-03
UCB EUR 2.18B 634M 2025-12